PL216661A1 - - Google Patents
Info
- Publication number
- PL216661A1 PL216661A1 PL21666179A PL21666179A PL216661A1 PL 216661 A1 PL216661 A1 PL 216661A1 PL 21666179 A PL21666179 A PL 21666179A PL 21666179 A PL21666179 A PL 21666179A PL 216661 A1 PL216661 A1 PL 216661A1
- Authority
- PL
- Poland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/132—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings
- C07C53/136—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing rings containing condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/921,371 US4177280A (en) | 1978-07-03 | 1978-07-03 | Bicyclo[3.1.0]hexyl-substituted carbonylaminophenoxy cardiovascular agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL216661A1 true PL216661A1 (pl) | 1980-03-24 |
| PL116994B1 PL116994B1 (en) | 1981-07-31 |
Family
ID=25445332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1979216661A PL116994B1 (en) | 1978-07-03 | 1979-06-27 | Process for manufacturing novel derivatives of 1-amino-3-phenoxypropan-2-olpropanola-2 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4177280A (pl) |
| EP (1) | EP0007710A1 (pl) |
| JP (1) | JPS559074A (pl) |
| AU (1) | AU4852379A (pl) |
| CA (1) | CA1105054A (pl) |
| DD (1) | DD148215A5 (pl) |
| DK (1) | DK276479A (pl) |
| ES (1) | ES482075A1 (pl) |
| IL (1) | IL57705A0 (pl) |
| NZ (1) | NZ190880A (pl) |
| PL (1) | PL116994B1 (pl) |
| SU (1) | SU854271A3 (pl) |
| ZA (1) | ZA793292B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402976A (en) * | 1981-04-24 | 1983-09-06 | E. R. Squibb & Sons, Inc. | Method for treating glaucoma with systemic nadolol compositions |
| EP0282127B1 (en) * | 1987-03-09 | 1994-02-02 | The Procter & Gamble Company | Beta-aminoethyl-substituted phenyl compounds, and anti-inflammatory or analgesic compositions containing them |
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| CN102379684B (zh) | 2005-04-28 | 2014-11-19 | 普罗透斯数字保健公司 | 药物信息系统 |
| KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료 |
| EP2398500B1 (en) | 2009-02-20 | 2019-03-13 | 2-BBB Medicines B.V. | Glutathione-based drug delivery system |
| ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| JP2020506895A (ja) * | 2017-01-17 | 2020-03-05 | ボード オブ レジェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System | インドールアミン２，３−ジオキシゲナーゼおよび／またはトリプトファンジオキシゲナーゼの阻害剤として有用な化合物 |
| WO2020018670A1 (en) | 2018-07-17 | 2020-01-23 | Board Of Regents, The University Of Texas System | Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1078852A (en) * | 1964-09-30 | 1967-08-09 | Ici Ltd | Alkanolamine derivatives |
| US4038313A (en) * | 1970-01-08 | 1977-07-26 | Ciba-Geigy Corporation | Cycloalkylureido phenoxy propanolamines |
| CA1149819A (en) * | 1970-01-08 | 1983-07-12 | Max Wilhelm | Process for the manufacture of new amines |
| US4038414A (en) * | 1972-06-08 | 1977-07-26 | Ciba-Geigy Corporation | Amines and processes for their manufacture |
| US4035420A (en) * | 1972-07-06 | 1977-07-12 | Aktiebolaget Hassle | Substituted ureido alkylene phenoxy propanolamines |
| AT334385B (de) * | 1973-12-20 | 1976-01-10 | Chemie Linz Ag | Verfahren zur herstellung von neuen phenoxypropylaminderivaten und deren salzen |
| US4063025A (en) * | 1975-02-05 | 1977-12-13 | Yamanouchi Pharmaceutical Co., Ltd. | 4-Substituted amino-α-aminomethylbenzyl alcohol derivatives |
| US4064258A (en) * | 1976-07-19 | 1977-12-20 | Syntex (U.S.A.) Inc. | Thiazole cardiovascular agents |
-
1978
- 1978-07-03 US US05/921,371 patent/US4177280A/en not_active Expired - Lifetime
-
1979
- 1979-06-27 PL PL1979216661A patent/PL116994B1/pl unknown
- 1979-06-29 NZ NZ190880A patent/NZ190880A/xx unknown
- 1979-06-29 ES ES482075A patent/ES482075A1/es not_active Expired
- 1979-06-29 CA CA331,064A patent/CA1105054A/en not_active Expired
- 1979-06-29 JP JP8153979A patent/JPS559074A/ja active Pending
- 1979-06-29 DK DK276479A patent/DK276479A/da not_active Application Discontinuation
- 1979-06-29 EP EP79301262A patent/EP0007710A1/en not_active Withdrawn
- 1979-06-29 AU AU48523/79A patent/AU4852379A/en not_active Abandoned
- 1979-07-02 IL IL57705A patent/IL57705A0/xx unknown
- 1979-07-02 SU SU792788053A patent/SU854271A3/ru active
- 1979-07-03 ZA ZA793292A patent/ZA793292B/xx unknown
- 1979-07-03 DD DD79214074A patent/DD148215A5/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS559074A (en) | 1980-01-22 |
| NZ190880A (en) | 1981-04-24 |
| US4177280A (en) | 1979-12-04 |
| AU4852379A (en) | 1980-01-10 |
| CA1105054A (en) | 1981-07-14 |
| SU854271A3 (ru) | 1981-08-07 |
| DD148215A5 (de) | 1981-05-13 |
| EP0007710A1 (en) | 1980-02-06 |
| ES482075A1 (es) | 1980-03-01 |
| DK276479A (da) | 1980-01-04 |
| ZA793292B (en) | 1981-02-25 |
| IL57705A0 (en) | 1979-11-30 |
| PL116994B1 (en) | 1981-07-31 |